Truvian raises $105 million to commercialize its automated blood-testing platform
Truvian, a startup developing an automated blood-testing platform, has raised $105 million to commercialize its product.Read More
Related Articles
Sales startup Insent.ai raises $2 million to expand its data strategy with automated chatbots
B2B enterprise sales platform Insent.ai has raised $2 million to expand its data visibility and automated chatbot integrations.
Contemplating automated testing? Calculate your ROI first
In software development, speed has become the defining characteristic of product launches. It sets the standard we can’t really escape anymore. It places demands on market players both old and new: release now, fix the issues later. Launch the feature today or watch your competitors outpace you. Meet the deadline or lose a vitally important partner/client. These are all thoughts and ideas most product managers, CTOs, and team leads have had (or heard). In part, I think the culprit for this state of affairs has been automation itself, as it has streamlined so many tech processes across industries and has… This story continues at The Next Web
Prophecy.io raises $6.75 million to expand its data engineering platform
Phrophecy.io, a startup developing a data engineering platform, has raised $6.75 million as it launches a SaaS version of its product.
Physna raises $20 million for AI that analyzes and digitizes 3D objects
Physna, a startup developing software that analyzes and digitizes 3D models, has raised $20 million in venture capital.
Responses